Recently, CSPC Pharmaceutical Innovation Pharmaceutical Co., Ltd. (hereinafter referred to as “CSPC Pharmaceutical Innovation”) has successfully passed the on-site audit of the BRCGS Food Safety System and obtained an A-grade rating. This marks another authoritative recognition for the company in international compliance development and quality control, further consolidating the foundation for its international growth.Originating in the UK, the BRCGS standard has evolved over years to become a widely recognized core specification in the global food industry.
Renowned for its systematic rigor and strictness, it serves as a key reference for major retailers, food brands and other enterprises worldwide when selecting partners. The certification covers every link from raw material procurement, production and warehousing logistics to personnel management. With a stringent and detailed assessment process, it represents a comprehensive evaluation of an enterprise’s overall capabilities.

CSPC Pharmaceutical Innovation has strictly adhered to the BRCGS standard system, comprehensively promoting the improvement and upgrading of its quality management system. In terms of infrastructure, the company has carried out refined renovations to its production environment, ensuring that all processes from equipment configuration to sanitation management meet high-standard requirements. For process control, a complete HACCP system has been established to enable precise management of risk points throughout the entire production process. In management systems, it has improved document control, traceability systems and emergency response procedures, guaranteeing full traceability and consistent quality from raw materials to finished products.
Regarding personnel management, multiple rounds of specialized training have been organized, integrating food safety awareness into corporate culture and turning it into conscious action for every employee. Although the process was challenging, it has significantly enhanced the company’s internal management and risk resilience.Building on the BRCGS standard, CS Pharmaceutical Innovation will continue to strengthen its quality management system, strictly uphold production standardization and product safety. Adhering to international benchmarks, the company will consistently provide global customers with safe, stable and efficient high-quality products and professional services.
